Evidence map›Paper›PMID 27354920›Full record

ArticleBiomaterials research2016

Multiple genetically engineered humanized microenvironments in a single mouse.

Jungwoo Lee, Dirk Heckl, Biju Parekkadan

Open access · goldAbstract read
In one paragraph

Article in Biomaterials research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Jungwoo LeeDepartment of Surgery, Center for Engineering in Medicine, Massachusetts General Hospital & Harvard Medical School and Shriners Hospital for Children, Boston, MA USA ; Department of Chemical Engineering, Institute for Applied Life Sciences, University of Massachusetts, Amherst, MA USA.
Dirk HecklDepartment of Medicine, Brigham and Women's Hospital, Boston, MA USA.
Biju ParekkadanDepartment of Surgery, Center for Engineering in Medicine, Massachusetts General Hospital & Harvard Medical School and Shriners Hospital for Children, Boston, MA USA ; Harvard Stem Cell Institute, Cambridge, MA USA.
Shriners Hospitals for Children - Erie · USBrigham and Women's Hospital · US

Funding

Artificial, Humanized Stem Cell NichesR01EB012521 · NIBIB · RUTGERS, THE STATE UNIV OF N.J. · PI PAREKKADAN, BIJU · 2011 to 2021
$6.0M
Elucidating Essential Components of Bone Marrow MetastasisR00CA163671 · NCI · UNIVERSITY OF MASSACHUSETTS AMHERST · PI LEE, JUNGWOO · 2014 to 2016
$740k
Peripheral Tissue Antigen Display by Mesenchymal Stem CellsK01DK087770 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI PAREKKADAN, BIJU · 2010 to 2014
$682k
NCI NIH HHS R00 CA163671NIBIB NIH HHS R01 EB012521NIDDK NIH HHS K01 DK087770
6 · The paper itself

Abstract

backgroundImmunodeficient mouse models that accept human cell and tissue grafts can contribute greater knowledge to human stem cell research. In this technical report, we used biomaterial implants seeded with genetically engineered stromal cells to create several unique microenvironments in a single mouse. The scope of study was focused on human CD34 hematopoietic stem/progenitor cell (HSPC) engraftment and differentiation within the engineered microenvironment.

resultsA mouse model system was created using subdermal implant sites that overexpressed a specific human cytokines (Vascular Endothelial Growth Factor A (hVEGFa), Stromal Derived Factor 1 Alpha (hSDF1a), or Tumor Necrosis Factor Alpha (hTNFa)) by stromal cells in a three-dimensional biomaterial matrix. The systemic exposure of locally overexpressed cytokines was minimized by controlling the growth of stromal cells, which led to autonomous local, concentrated sites in a single mouse for study. This biomaterial implant approach allowed for the local analysis of each cytokine on hematopoietic stem cell recruitment, engraftment and differentiation in four different tissue microenvironments in the same host. The engineered factors were validated to have bioactive effects on human CD34+ hematopoietic progenitor cell differentiation.

conclusionsThis model system can serve as a new platform for the study of multiple human proteins and their local effects on hematopoietic cell biology for in vivo validation studies.

Indexed as

Bone marrow stromal cellsChimeric mouse modelGenetically engineered stromaHuman hematopoietic stem and progenitor cellsImplantable microenvironmentsScaffolds

Identifiers

PMID27354920
PMCPMC4924259
OpenAlexW2461617634

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.